Stereotaxis, Inc. (STXS) Financial Ratios
24 years of historical data (2002–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
9.13
↓-11% vs avg
5yr avg: 10.28
30Y Low1.9·High32.8
ROE
↓
-143.6%
↑-62% vs avg
5yr avg: -88.6%
30Y Low-443%·High2%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
STXS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Stereotaxis, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $184M | $209M | $194M | $141M | $157M | $468M | $370M | $334M | $56M | $18M | $14M |
| Enterprise Value | $176M | $201M | $188M | $127M | $155M | $436M | $331M | $308M | $46M | $14M | $6M |
| P/E Ratio → | -7.52 | — | — | — | — | — | — | — | 491.36 | — | — |
| P/S Ratio | 5.68 | 6.46 | 7.22 | 5.28 | 5.59 | 13.38 | 13.90 | 11.54 | 1.92 | 0.58 | 0.44 |
| P/B Ratio | 9.13 | 11.17 | 16.99 | 6.44 | 4.93 | 11.88 | 9.20 | 11.69 | 7.74 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
STXS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 6.21 | 6.98 | 4.74 | 5.50 | 12.44 | 12.42 | 10.65 | 1.55 | 0.46 | 0.18 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
STXS Profitability
Margins and return-on-capital ratios measuring operating efficiency
Stereotaxis, Inc. earns an operating margin of -68.3%. Operating margins have expanded from -81.6% to -68.3% over the past 3 years, signaling improving operational efficiency. A negative ROE of -143.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.7% | 52.7% | 54.2% | 55.5% | 65.6% | 66.3% | 71.2% | 78.8% | 80.5% | 65.5% | 76.6% |
| Operating Margin | -68.3% | -68.3% | -91.9% | -81.6% | -66.7% | -36.8% | -25.2% | -16.7% | -8.4% | -19.0% | -20.0% |
| Net Profit Margin | -66.8% | -66.8% | -89.3% | -77.4% | -65.0% | -30.6% | -25.0% | -15.9% | 0.4% | -18.9% | -16.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -143.6% | -143.6% | -144.2% | -76.9% | -51.3% | -26.9% | -19.3% | -25.7% | 1.6% | — | — |
| ROA | -43.7% | -43.7% | -54.3% | -43.5% | -32.0% | -18.4% | -13.4% | -14.8% | 0.8% | -37.2% | -26.3% |
| ROIC | -207.9% | -207.9% | -289.6% | -89.0% | -78.2% | -256.7% | -294.8% | — | — | — | — |
| ROCE | -80.4% | -80.4% | -92.0% | -64.4% | -43.2% | -28.8% | -18.3% | -24.3% | -29.5% | — | — |
STXS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $13M exceeds total debt of $5M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.29 | 0.53 | 0.25 | 0.18 | 0.15 | 0.11 | 0.15 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.43 | -0.54 | -0.65 | -0.09 | -0.83 | -0.98 | -0.91 | -1.48 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -1279.71 | — | — | -148.32 | -32.92 | -2.59 |
Net cash position: cash ($13M) exceeds total debt ($5M)
STXS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.51x means Stereotaxis, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.09x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.51x to 1.51x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | 1.51 | 1.22 | 2.51 | 3.03 | 3.87 | 3.88 | 3.19 | 1.76 | 0.33 | 0.54 |
| Quick Ratio | 1.09 | 1.09 | 0.84 | 1.88 | 2.47 | 3.54 | 3.64 | 3.04 | 1.65 | 0.29 | 0.39 |
| Cash Ratio | 0.60 | 0.60 | 0.57 | 1.50 | 1.99 | 2.92 | 3.24 | 2.48 | 1.06 | 0.12 | 0.24 |
| Asset Turnover | — | 0.62 | 0.58 | 0.64 | 0.53 | 0.57 | 0.48 | 0.66 | 1.59 | 2.92 | 1.53 |
| Inventory Turnover | 1.60 | 1.60 | 1.48 | 1.41 | 1.23 | 2.66 | 2.33 | 3.32 | 4.80 | 9.38 | 1.40 |
| Days Sales Outstanding | — | 65.92 | 51.85 | 52.11 | 66.01 | 56.34 | 48.18 | 67.31 | 62.45 | 50.25 | 52.95 |
STXS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Stereotaxis, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | 0.2% | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $91M | $85M | $81M | $76M | $76M | $73M | $63M | $52M | $23M | $22M |
Peer Comparison
Compare STXS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 STXSYou | $184M | -7.5 | — | — | 52.7% | -68.3% | -143.6% | -207.9% | — |
 ISRG | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 ABT | $154B | 11.6 | 16.1 | 24.2 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 IRTC | $3B | -75.3 | — | 99.6 | 70.6% | -4.9% | -36.6% | -5.2% | — |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 BEAT | $26M | -1.2 | — | — | — | — | -987.3% | — | — |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 ZBH | $17B | 24.8 | 9.8 | 11.7 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 24 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
STXS — Frequently Asked Questions
Quick answers to the most common questions about buying STXS stock.
What is Stereotaxis, Inc.'s P/E ratio?
Stereotaxis, Inc.'s current P/E ratio is -7.5x. This places it at the 50th percentile of its historical range.
What is Stereotaxis, Inc.'s ROE?
Stereotaxis, Inc.'s return on equity (ROE) is -143.6%. The historical average is -123.7%.
Is STXS stock overvalued?
Based on historical data, Stereotaxis, Inc. is trading at a P/E of -7.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Stereotaxis, Inc.'s profit margins?
Stereotaxis, Inc. has 52.7% gross margin and -68.3% operating margin.